Search results
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
1 No-Brainer Growth Stock to Buy and Hold | The Motley Fool
The Motley Fool· 4 days agoAll of these superlatives (and more) describe Eli Lilly's (LLY -1.50%) performance in recent years...
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters· 5 days ago, opens new tab to market its blockbuster obesity treatment drugs in India, the company's CEO said...
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
InvestorPlace· 21 hours agoBiotechnology is an interesting place to look if you’re looking for growth and are not put off by...
Market Digest: NDAQ, GOLD, ADTN, AJG, EMR, HLF, LLY, JCI, CHTR
Argus Research via Yahoo Finance· 21 hours agoWhile long-term insider-sentiment readings from Vickers Stock Research are improving from recent lows, shorter-term readings have yet to find consistent footing. Indeed, the one-week sell/buy ...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 7 days agoUtilizing one-week price change and the monthly percentage change in earnings estimates, among other...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 4 days agoThanks to their market-leading positions and blockbuster drugs, stocks like Novo Nordisk (NYSE:...
Wegovy users keep weight off for four years, Novo Nordisk study says
Reuters· 16 hours ago, opens new tab Wegovy obesity treatment maintained an average of 10% weight loss after four years,...
Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
Zacks· 5 days agoEaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
Morningstar· 2 days agoWith strong pricing power and sales growth of key drugs, here’s what we think of Lilly’s stock. Eli...